AusCann Group (AC8) Stock Price, News & Analysis

Company Overview

AusCann Group Holdings Ltd engages in the development and commercialization of cannabinoid-derived therapeutic products for humans and animals in Australia and internationally. Its principal product includes the novel tetrahydrocannabinol and cannabidiol (THC/CBD), a powder-based hard-shell capsules based on AusCann's Neuvis platform for the treatment of pain and related indications. The company is also involved in the research and development of medicinal cannabis. It offers its products to healthcare professionals and veterinarians. AusCann Group Holdings Ltd is based in West Perth, Australia.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 537,446 shs
• Average Volume: N/A
• Market Capitalization: $17.62 million
• P/E Ratio: N/A
• Dividend Yield: 6.79%
• Price Target: N/A
• Consensus Rating: N/A

AC8 Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of AusCann Group own?

Based on aggregate information from My MarketBeat watchlists, some other companies that AusCann Group investors own include 3D Systems (DDD), Bristol-Myers Squibb (BMY), Johnson & Johnson (JNJ), Workday (WDAY), Zoom Video Communications (ZM), Zynerba Pharmaceuticals (ZYNE) and Ambarella (AMBA).

Industry, Sector and Symbol

• Stock Exchange: ASX
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: N/A
• Current Symbol: ASX:AC8
• CUSIP: N/A
• CIK: N/A
• Web: www.auscann.com.au
• Phone: 61 0 9561 8834
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): A($0.06)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-9,440,000.00
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: -1.09%
• Return on Assets: -1.67%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 33.22
• Quick Ratio: 20.17

Sales & Book Value

• Annual Sales: $1.36 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: 2.05
• Book Value: A$0.01 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 440,550,000
• Free Float: N/A
• Market Cap: $17.62 million
• Optionable: Not Optionable
• Beta: 0.72